BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, cilt.86, sa.6, ss.676-686, 2020 (SCI-Expanded)
Introduction: Three-weekly cisplatin dose is accepted for standard treatment for concurrent chemo-radiotherapy in nasopharyngeal carcinoma. However, different chemotherapy schedules are presented in the literature.